An experimental HIV vaccine regimen from scientists at Scripps Research and Karolinska Institutet elicited apex-targeted cross-neutralizing antibodies in every preclinical model tested. Published in Nature the vaccines generated responses against multiple HIV strains. More: https://ow.ly/pfKk50Z5Hcp
